410 related articles for article (PubMed ID: 28320418)
1. Ovarian cancer stem cells: still an elusive entity?
Lupia M; Cavallaro U
Mol Cancer; 2017 Mar; 16(1):64. PubMed ID: 28320418
[TBL] [Abstract][Full Text] [Related]
2. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
[TBL] [Abstract][Full Text] [Related]
3. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
[TBL] [Abstract][Full Text] [Related]
4. Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer.
Nieddu V; Melocchi V; Battistini C; Franciosa G; Lupia M; Stellato C; Bertalot G; Olsen JV; Colombo N; Bianchi F; Cavallaro U
Cell Death Dis; 2023 Mar; 14(3):220. PubMed ID: 36977707
[TBL] [Abstract][Full Text] [Related]
5. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N; Abubaker K; Findlay J; Quinn M
J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
[TBL] [Abstract][Full Text] [Related]
6. IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.
Wang Y; Zong X; Mitra S; Mitra AK; Matei D; Nephew KP
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518684
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.
Lučić I; Kurtović M; Mlinarić M; Piteša N; Čipak Gašparović A; Sabol M; Milković L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445860
[TBL] [Abstract][Full Text] [Related]
8. Role of the microenvironment in ovarian cancer stem cell maintenance.
Pasquier J; Rafii A
Biomed Res Int; 2013; 2013():630782. PubMed ID: 23484135
[TBL] [Abstract][Full Text] [Related]
9. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
10. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
11. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ovarian cancer stem cells or tumor-initiating cells.
Kwon MJ; Shin YK
Int J Mol Sci; 2013 Mar; 14(4):6624-48. PubMed ID: 23528891
[TBL] [Abstract][Full Text] [Related]
14. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
18. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
19. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.
Yang T; Cheng J; You J; Yan B; Liu H; Li F
Oncol Rep; 2018 Sep; 40(3):1574-1582. PubMed ID: 29956807
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer stem cells: What progress have we made?
Al-Alem LF; Pandya UM; Baker AT; Bellio C; Zarrella BD; Clark J; DiGloria CM; Rueda BR
Int J Biochem Cell Biol; 2019 Feb; 107():92-103. PubMed ID: 30572025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]